Alejandra López‐Ibáñez de Aldecoa
Biographic Data
| ID | 10243250 |
|---|---|
| NAME | Alejandra López‐Ibáñez de Aldecoa |
| GIVEN NAMES | Alejandra López‐Ibáñez |
| FAMILY NAME | de Aldecoa |
| SIGNATURE | DE ALDECOA A L I |
| AFFILIATIONS | Pfizer (Spain) |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2026 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Resource use and economic burden of respiratory syncytial virus among older adults in real-world clinical practice across five European countries
Introduction The impact of respiratory syncytial virus (RSV) is increasingly being recognized in older adults, however economic burden data is sparse. This study describes the burden of RSV and associated direct and indirect costs in adults aged 60 + years in real-world clinical practice across five European countries. Methods Data were drawn from the Adelphi RSV Disease Specific Program (DSPTM), a cross-sectional survey of physicians and patient…
No prominent works on this page.
Resource use and economic burden of respiratory syncytial virus among older adults in real-world clinical practice across five European countries
Introduction The impact of respiratory syncytial virus (RSV) is increasingly being recognized in older adults, however economic burden data is sparse. This study describes the burden of RSV and associated direct and indirect costs in adults aged 60 + years in real-world clinical practice across five European countries. Methods Data were drawn from the Adelphi RSV Disease Specific Program (DSPTM), a cross-sectional survey of physicians and patient…
Clinical Practice (1 work) · Cystic Fibrosis Research Advances (1 work) · Delphi Technique in Research (1 work) · Disease (1 work) · Disease burden (1 work) · Health care (1 work) · Indirect costs (1 work) · MEDLINE (1 work) · Productivity (1 work) · Resource use (1 work)